DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CEFAZOLIN SODIUM

« Back to Dashboard

All Clinical Trials for Cefazolin Sodium

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01127880	Role of Antibiotics to Reduce Infectious Complications in Tube Thoracotomy Management of Traumatic Hemopneumothorax	Completed	St. Luke's Hospital, Pennsylvania	Phase 2/Phase 3	2005-07-01	The purpose of this study is to examine the efficacy of prophylactic antibiotics in patients with chest tubes for management of thoracic injuries in the reduction of the incidence of empyema as compared to placebo.
NCT01273818	Effectiveness of Topical Antibiotic Prophylaxis in Inguinal Hernia Repair	Completed	Diskapi Teaching and Research Hospital	Phase 4	2011-01-01	Aim of this study is to measure the effectiveness of topical gentamicin to prevent post-operative infection in inguinal tension-free hernia repair operation.Secondary aim is, if it is effective as a prophylactic agent, to compare it's effect with intra venous single dose cefazolin sodium prophylaxis.
NCT01805856	Antimicrobial Prophylaxis in Thyroid and Parathyroid Surgery	Completed	Ito Hospital	N/A	2010-11-01	The effectiveness of antimicrobial prophylaxis (AMP) for prevention of surgical site infection (SSI) following thyroid and parathyroid surgery remains uncertain. Present prospective randomized control study (Ito-RCT1) assessed the effectiveness of AMP in clean neck surgery associated with thyroid and parathyroid disease.
NCT02017197	Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil	Completed	Fundação de Amparo à Pesquisa do Estado de São Paulo	Phase 4	2014-08-01	The purpose of this study is to assess whether the switch from branded to generic warfarin or between different generic warfarin tablets may cause fluctuation in the results of coagulation tests (International Normalized Rate, acronym INR) in patients, thus predisposing them to unnecessary risks.
NCT02017197	Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil	Completed	Federal University of São Paulo	Phase 4	2014-08-01	The purpose of this study is to assess whether the switch from branded to generic warfarin or between different generic warfarin tablets may cause fluctuation in the results of coagulation tests (International Normalized Rate, acronym INR) in patients, thus predisposing them to unnecessary risks.

Clinical Trial Conditions for Cefazolin Sodium

Condition Name

Condition Name for Cefazolin Sodium
Intervention	Trials
Cesarean Section Complications	1
Surgical Site Infection	1
Atrial Fibrillation	1
Pneumothorax	1

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Cefazolin Sodium
Intervention	Trials
Surgical Wound Infection	2
Hemopneumothorax	1
Parathyroid Diseases	1
Infection	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Cefazolin Sodium

Trials by Country

Trials by Country for Cefazolin Sodium
Location	Trials
United States	1
Brazil	1
Japan	1
Turkey	1
Egypt	1

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Cefazolin Sodium
Location	Trials
Pennsylvania	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Cefazolin Sodium

Clinical Trial Phase

Clinical Trial Phase for Cefazolin Sodium
Clinical Trial Phase	Trials
Phase 4	2
Phase 2/Phase 3	1
N/A	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Cefazolin Sodium
Clinical Trial Phase	Trials
Completed	4
Not yet recruiting	1
Recruiting	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Cefazolin Sodium

Sponsor Name

Sponsor Name for Cefazolin Sodium
Sponsor	Trials
St. Luke's Hospital, Pennsylvania	1
University of British Columbia	1
Aswan University Hospital	1

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Cefazolin Sodium
Sponsor	Trials
Other	7

Export unavailable in trial.
Subscribe for complete access.